Abstract
Benchmarks for molecular docking have historically focused on re-docking the cognate ligand of a well-determined protein–ligand complex to measure geometric pose prediction accuracy, and measurement of virtual screening performance has been focused on increasingly large and diverse sets of target protein structures, cognate ligands, and various types of decoy sets. Here, pose prediction is reported on the Astex Diverse set of 85 protein ligand complexes, and virtual screening performance is reported on the DUD set of 40 protein targets. In both cases, prepared structures of targets and ligands were provided by symposium organizers. The re-prepared data sets yielded results not significantly different than previous reports of Surflex-Dock on the two benchmarks. Minor changes to protein coordinates resulting from complex pre-optimization had large effects on observed performance, highlighting the limitations of cognate ligand re-docking for pose prediction assessment. Docking protocols developed for cross-docking, which address protein flexibility and produce discrete families of predicted poses, produced substantially better performance for pose prediction. Performance on virtual screening performance was shown to benefit by employing and combining multiple screening methods: docking, 2D molecular similarity, and 3D molecular similarity. In addition, use of multiple protein conformations significantly improved screening enrichment.
Similar content being viewed by others
References
Kuntz ID, Blaney JM, Oatley SJ, Langridge R, Ferrin TE (1982) J Mol Biol 161:269
Goodsell DS, Olson AJ (1990) Proteins 8:195
Goodsell DS, Morris GM, Olson AJ (1996) J Mol Recognit 9:1
Jones G, Willett P, Glen RC (1995) J Mol Biol 245:43
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) J Mol Biol 267:727
Welch W, Ruppert J, Jain AN (1996) Chem Biol 3:449
Jain AN (1996) J Comput Aided Mol Des 10:427
Ruppert J, Welch W, Jain AN (1997) Protein Sci 6:524
Rarey M, Kramer B, Lengauer T, Klebe G (1996) J Mol Biol 261:470
Rarey M, Kramer B, Lengauer T (1997) J Comput Aided Mol Des 11:369
Bissantz C, Folkers G, Rognan D (2000) J Med Chem 43:4759
Jain AN (2003) J Med Chem 46:499
Perola E, Walters WP, Charifson PS (2004) Proteins 56:235
Warren GL, Andrews CW, Capelli AM, Clarke B, LaLonde J, Lambert MH, Lindvall M, Nevins N, Semus SF, Senger S, Tedesco G, Wall ID, Woolven JM, Peishoff CE, Head MS (2006) J Med Chem 49:5912
Pham TA, Jain AN (2006) J Med Chem 49:5856
Huang N, Shoichet BK, Irwin JJ (2006) J Med Chem 49:6789
Hartshorn MJ, Verdonk ML, Chessari G, Brewerton SC, Mooij WT, Mortenson PN, Murray CW (2007) J Med Chem 50:726
Sutherland JJ, Nandigam RK, Erickson JA, Vieth M (2007) J Chem Inf Model 47:2293
Verdonk ML, Mortenson PN, Hall RJ, Hartshorn MJ, Murray CW (2008) J Chem Inf Model 48:2214
Jain AN, Nicholls A (2008) J Comput Aided Mol Des 22:133
Jain AN (2008) J Comput Aided Mol Des 22:201
Warren G, McGaughey GB, Nevins N (2012) J Comput Aided Mol Des, this issue
Jain AN (2009) J Comput Aided Mol Des 23:355
Cross JB, Thompson DC, Rai BK, Baber JC, Fan KY, Hu Y, Humblet C (2009) J Chem Inf Model 49:1455
Jain AN (2007) J Comput Aided Mol Des 21:281
Cleves AE, Jain AN (2006) J Med Chem 49:2921
Cleves AE, Jain AN (2008) J Comput Aided Mol Des 22:147
Jain AN (2004) J Med Chem 47:947
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) J Med Chem 47(7):1739–1749
Spitzer R, Cleves AE, Jain AN (2011) Proteins 79:2746
Chen X, Lin Y, Liu M, Gilson MK (2002) Bioinformatics 18:130
Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH (2009) Nucleic Acids Res 37:W623
Perkins E, Sun D, Nguyen A, Tulac S, Francesco M, Tavana H, Nguyen H, Tugendreich S, Barthmaier P, Couto J, Yeh E, Thode S, Jarnagin K, Jain AN, Morgans D, Melese T (2001) Cancer Res 61:4175
Jain AN (2000) J Comput Aided Mol Des 14:199
Hawkins PC, Skillman AG, Nicholls A (2007) J Med Chem 50:74
Nicholls A, McGaughey GB, Sheridan RP, Good AC, Warren G, Mathieu M, Muchmore SW, Brown SP, Grant JA, Haigh JA, Nevins N, Jain AN, Kelley B (2010) J Med Chem 53:3862
Acknowledgments
The authors gratefully acknowledge NIH for partial funding of the work (grant GM070481) and Ann Cleves for comments on the manuscript. Dr. Jain has a financial interest in BioPharmics LLC, a biotechnology company whose main focus is in the development of methods for computational modeling in drug discovery. Tripos Inc. has exclusive commercial distribution rights for Surflex-Dock and Surflex-Sim, licensed from BioPharmics LLC.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spitzer, R., Jain, A.N. Surflex-Dock: Docking benchmarks and real-world application. J Comput Aided Mol Des 26, 687–699 (2012). https://doi.org/10.1007/s10822-011-9533-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-011-9533-y